Inflammatory Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia
Farrell-Sherman, A.; de la Force, N.; Prator, C.; Valieris, R.; Azam, W.; Silva, I.; Deeks, S.; Thanh, C.; Bosch, R.; Henrich, T. J.; Cohn, L. B.
Show abstract
The persistence of HIV-1 proviruses in latently infected cells allows viremia to resume upon treatment cessation. To characterize the resulting immune response, we compare plasma proteomics and single-cell transcriptomics of peripheral blood mononuclear cells (PBMCs) before, during, and after detectable plasma viremia. We observe unique transcriptional signatures prior to viral rebound including a significant increase in CD16++ monocytes with increased anti-viral gene expression. Inflammatory proteins were identified in plasma after detectable rebound. Identifying early signals of imminent viral rebound after treatment cessation will aid in the development of strategies to prolong time to viral rebound and cure HIV-1.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- No Evidence that Ongoing HIV-Specific Immune Responses Contribute to Persistent Inflammation and Immune Activation in Persons on Long-Term ART 97%
- Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence 95%
- Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size 95%
Similar papers in this journal
- Impact of cannabis use on immune cell populations and the viral reservoir in people with HIV on suppressive antiretroviral therapy. 94%
- Frequent development of broadly neutralizing antibodies in early life in a large cohort of HIV-infected children 93%
- Elite neutralizers of human cytomegalovirus are characterized by high magnitude plasma IgG responses against multiple glycoprotein complexes 92%
Similar papers in this journal
- Antiretroviral treatment-induced decrease in immune activation contributes to reduced susceptibility to tuberculosis in HIV-1-TB co-infected persons 95%
- Contrasting inflammatory signatures in peripheral blood and bronchoalveolar cells reveal compartment-specific effects of HIV infection. 93%
- MR1-restricted MAIT cells from the human lung mucosal surface have distinct phenotypic, functional, and transcriptomic features that are preserved in HIV infection 93%
Similar papers in this journal
- Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection 96%
- HIV infection alters SARS-CoV-2 responsive immune parameters but not clinical outcomes in COVID-19 disease 95%
- Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors 95%
Similar papers in this journal
- Changes in Cerebrospinal Fluid Proteins across the Spectrum of Untreated and Treated Chronic HIV-1 Infection 95%
- Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers 94%
- Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.